Medical Information Only. Consult your healthcare provider before enrolling in any clinical trial.
Nebraska: below-average open trial sites
382 of 1,301 in-state trials are recruiting (29%); below the 37% national average by 8 percentage points.
According to ClinicalTrials.gov-derived indexes, Nebraska sits in the lower half of US states by in-state trial count (#34 of 52 states by registered in-state trial count).
Nebraska: 1,301 US clinical trials with in-state sites, 382 recruiting.
Nebraska has 1,301 registered US clinical trials with a study site in-state, 382 of them currently recruiting (below the 37% national average by 8 percentage points). 301 of these trials are in Phase 3 (late-stage) and 359 in Phase 2. The most frequently studied condition in Nebraska is Healthy, with 28 linked trials.
Lower-half Nebraska archive
Nebraska's in-state trials target 5,491 patients on average (p76 by trial size among 52 states with enrollment data), larger, multi-site studies than most states. Treat this page as a compact local index (mid-volume · low-open), then jump to recruiting trials or methodology rather than expecting hub-scale coverage.
Below-average open enrollment
Nebraska still shows 382 recruiting of 1,301 in-state trials (29% open), but below the 37% national average by 8 percentage points, so archived statuses weigh heavier than the national baseline.
- 29%
- open (below national share)
- 382
- still recruiting despite cool share
- 359
- Phase 2 rows in this footprint
- 28
- top: Healthy
Recruiting share is below the 37% national average by 8 percentage points. Counts include every study with at least one recorded site in the state. Registry reference only, not medical advice.
Nebraska vs all states by indexed in-state trial count
Where this state's ClinicalTrials.gov site count sits among every state with at least one listed trial (coverage density, not care quality)
1,301 Top 65% more indexed trials than 35% of 52 states
States, banded by indexed in-state trial count
Each bar is a band; taller bars hold more states. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov · 2026-08-08
Key findings
What ClinicalTrials.gov does not surface for Nebraska on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Nebraska open-enrollment share sits below the national baseline.
382 of 1,301 in-state trials (29.4%) are recruiting, against 37% nationally (-7.6 percentage points). Counts include every study with at least one recorded site in the state.
-
Omaha dominates Nebraska's trial geography.
Omaha lists 997 of 1,301 in-state trials (76.6%) across 357 named facilities. Cities need five or more listed trials to appear here; locations are as filed by sponsors.
-
Healthy is the most-studied condition in Nebraska.
28 of 1,301 in-state trials (2.2%) list Healthy. That is a local concentration figure, not a national disease ranking.
-
Nebraska sponsorship is fragmented across many organizations.
University of Nebraska appears on 123 of 1,301 in-state trials (9.5%). Sponsor identity is as filed on ClinicalTrials.gov.
-
Most Nebraska indexed trials have already finished enrollment.
658 of 1,301 (50.6%) are completed. The open share above is the remainder that still lists recruiting.
By Status
| Status | Trial count |
|---|---|
| Completed | 658 |
| Recruiting | 382 |
| Active | 261 |
By Phase
| Phase | Trial count |
|---|---|
| Phase 2 | 359 |
| Phase 3 | 301 |
| Phase 1 | 235 |
| NA | 203 |
| Phase 4 | 74 |
| Early Phase 1 | 4 |
Top Conditions
Top Sponsors
Where trials run in Nebraska
Omaha carries 997 of Nebraska's 1,301 indexed trials (77%) across 357 named sites, ahead of Lincoln at 253. 8 cities clear five listed trials, together naming 582 distinct sites.
| City | Trials | Listed sites |
|---|---|---|
| Omaha | 997 | 357 |
| Lincoln | 253 | 150 |
| Bellevue | 26 | 21 |
| Grand Island | 24 | 18 |
| Norfolk | 20 | 10 |
| Papillion | 18 | 17 |
| Boys Town | 9 | 3 |
| Hastings | 7 | 6 |
Distinct trials and named sites per city, as filed with ClinicalTrials.gov; cities under five trials omitted. Vintage 2026-08-08.
Trial size large
Nebraska's in-state trials target 5,491 patients on average (p76 by trial size among 52 states with enrollment data), larger, multi-site studies than most states.
Nebraska: in-state trial volume sits mid-pack
Geography is concentrated: Omaha alone accounts for 77% of Nebraska's indexed trials (997 of 1,301), with Lincoln a distant second at 253.
Phase mix: 301 Phase 3 vs 359 Phase 2 (balanced across stages).
Top condition: Healthy (28 trials); top sponsor University of Nebraska (123).
mid-volume · low-open figures (1,301 trials · 29% open) describe registry geography under the trial size large read, not clinic capacity or protocol fit. Confirm status on ClinicalTrials.gov before acting.
States near Nebraska on in-state trial volume
Cross-state peers under the trial size large read (mid-volume · low-open), not the same-state browse list.
Similar mid-volume peers (± open share)
- Oklahoma · 1,061 trials · 34% recruiting
- Iowa · 1,544 trials · 33% recruiting
- Nevada · 900 trials · 27% recruiting
- South Carolina · 1,706 trials · 35% recruiting
- Utah · 1,734 trials · 38% recruiting
Similar low-open peers (± trial volume)
- Kansas · 29% recruiting · 2,080 trials
- New Mexico · 29% recruiting · 579 trials
- Indiana · 29% recruiting · 3,113 trials
- Alabama · 29% recruiting · 4,168 trials
- Arizona · 30% recruiting · 5,607 trials